Skip to main content
. 2017 Sep 1;7(4):195–203.

Table 2.

Results from OLINDA 1.1 estimating the dose using all three subjects but only the first two scans to generate the TAC from which average residence times were calculated

Target Organ Alpha Beta Photon Total EDE Cont. ED Cont.
Adrenals 0.00E000 1.24E-02 4.67E-01 4.79E-01 2.87E-02 2.40E-03
Brain 0.00E000 1.24E-02 5.11E-02 6.35E-02 0.00E000 3.18E-04
Breasts 0.00E000 1.24E-02 1.22E-01 1.35E-01 2.02E-02 6.75E-03
Gallbladder Wall 0.00E000 1.24E-02 7.74E-01 7.86E-01 4.72E-02 0.00E000
LLI Wall 0.00E000 9.90E-02 1.78E-01 2.77E-01 0.00E000 3.32E-02
Small Intestine 0.00E000 1.23E-01 2.69E-01 3.92E-01 0.00E000 1.96E-03
Stomach Wall 0.00E000 3.62E-02 2.67E-01 3.04E-01 0.00E000 3.64E-02
ULI Wall 0.00E000 7.98E-02 3.58E-01 4.38E-01 0.00E000 2.19E-03
Heart Wall 0.00E000 1.06E-01 3.43E-01 4.49E-01 0.00E000 0.00E000
Kidneys 0.00E000 2.18E-01 5.30E-01 7.49E-01 4.49E-02 3.74E-03
Liver 0.00E000 8.02E-01 1.68E000 2.48E000 1.49E-01 1.24E-01
Lungs 0.00E000 4.17E-02 2.47E-01 2.89E-01 3.47E-02 3.47E-02
Muscle 0.00E000 1.24E-02 1.41E-01 1.53E-01 0.00E000 7.67E-04
Ovaries 0.00E000 1.24E-02 1.87E-01 1.99E-01 4.99E-02 3.99E-02
Pancreas 0.00E000 1.24E-02 4.37E-01 4.49E-01 0.00E000 2.25E-03
Red Marrow 0.00E000 9.09E-03 1.66E-01 1.76E-01 2.11E-02 2.11E-02
Osteogenic Cells 0.00E000 3.18E-02 1.34E-01 1.66E-01 4.97E-03 1.66E-03
Skin 0.00E000 1.24E-02 8.62E-02 9.87E-02 0.00E000 9.87E-04
Spleen 0.00E000 4.36E-01 5.97E-01 1.03E000 6.20E-02 5.16E-03
Testes 0.00E000 1.24E-02 6.66E-02 7.90E-02 0.00E000 0.00E000
Thymus 0.00E000 1.24E-02 1.36E-01 1.48E-01 0.00E000 7.40E-04
Thyroid 0.00E000 1.24E-02 7.59E-02 8.84E-02 2.65E-03 4.42E-03
Urinary Bladder Wall 0.00E000 1.24E-02 1.10E-01 1.23E-01 0.00E000 6.13E-03
Uterus 0.00E000 1.24E-02 1.62E-01 1.74E-01 0.00E000 8.71E-04
Total Body 0.00E000 3.77E-02 1.83E-01 2.21E-01 0.00E000 0.00E000
Effective Dose Equivalent (mSv/MBq) 4.65E-01
Effective Dose (mSv/MBq) 3.30E-01